Jun Peng*

Dr. Jun Peng*


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2026 in Cells
Verified
Journal Article
Open access
PDF file
YYYijing Yang
Yijing Yang
PLPei Liu
Pei Liu
JLJiangwei Li
Jiangwei Li
YDYing Deng
Ying Deng
LXLi Xiao
Li Xiao
JPJun Peng*
Jun Peng*
The retinal pigment epithelium (RPE) is a long-lived, highly polarised epithelial monolayer that performs essential functions in retinal homeostasis, including outer blood–retina barrier maintenance, visual cycle activity, metabolic exchange, phagocytic clearance of photoreceptor outer segments, and regulation of oxidative and immune balance. Because RPE cells persist for decades under conditions of sustained oxidative, metabolic, and phagocytic stress, this tissue provides a valuable model for examining how long-lived post-mitotic cells preserve function over time and how age-related dysfunction emerges when that balance weakens. Although much of the current literature on RPE ageing has been shaped by age-related macular degeneration (AMD), age-dependent change in the RPE should not be understood solely as a preclinical stage of disease. Rather, the ageing RPE offers a broader framework for studying cellular maintenance under chronic physiological load. In this review, we synthesise current evidence on RPE ageing across four interrelated domains: structural remodelling, mitochondrial and metabolic imbalance, proteostatic and lysosomal burden, and chronic inflammatory dysregulation. Across these processes, ageing in the RPE is expressed less as widespread cell loss than as progressive decline in cellular organisation, buffering capacity, and functional precision. Structural irregularity, altered mitochondrial regulation, incomplete degradative clearance, and persistent low-grade inflammatory signalling together reduce the ability of the RPE to maintain long-term homeostasis and increase vulnerability to age-related retinal dysfunction. We further argue that ageing in the RPE is best understood not as abrupt failure of isolated pathways, but as gradual loss of system coherence among interacting homeostatic systems that remain active while operating under increasing constraint. This view helps integrate diverse cellular and molecular findings and highlights the RPE as an informative model for understanding ageing in long-lived post-mitotic tissues.

28 September 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
YZYuan Zhong
Yuan Zhong
JSJian Shi
Jian Shi
XLXiyuan Liu
Xiyuan Liu
YZYanwen Zhang
Yanwen Zhang
QPQinghua Peng
Qinghua Peng
JPJun Peng*
Jun Peng*
Background: Persistent ocular surface inflammation and lacrimal gland immune dysregulation are central to the progression of dry eye disease (DED). Th17/Treg imbalance contributes to sustained inflammatory activation in the ocular surface and lacrimal gland. Yiguanjian (YGJ) has anti-inflammatory and immunomodulatory potential, but whether it can alleviate ocular surface inflammation and restore lacrimal gland immune homeostasis in DED remains unclear. Methods: A benzalkonium chloride (BAC)-induced rat DED model was used to assess the effects of YGJ on tear secretion, tear film break-up time, corneal fluorescein staining, ocular histopathology, lacrimal gland Th17/Treg proportions, related gene expression, and STAT3 signaling. Yiguanjian-containing serum (YCS) was prepared, and its serum-associated chemical features were characterized by UHPLC-Q-Orbitrap HRMS. A hyperosmotic non-contact co-culture system of rat lacrimal gland epithelial cells and activated CD4⁺ T cells was established to evaluate epithelial cell viability, intracellular reactive oxygen species (ROS), Th17/Treg differentiation, Foxp3 and IL-17A immunofluorescence signals, and related gene expression. AS2863619 and Peptide P60 were used to explore Foxp3-associated regulation. Results: In BAC-induced dry eye rats, YGJ improved tear secretion and tear film stability, reduced corneal fluorescein staining, and alleviated corneal and lacrimal gland histopathological injury, with partial preservation of meibomian gland and conjunctival morphology. YGJ reduced lacrimal gland Th17 proportions, restored Treg proportions, increased Foxp3 and IL-10 expression, decreased RORγt and IL-17A expression, and reduced lacrimal gland STAT3 phosphorylation. UHPLC-Q-Orbitrap HRMS yielded 67 candidate annotations corresponding to 56 distinct LC–MS features in YCS. In the hyperosmotic co-culture model, YCS improved epithelial cell viability, reduced ROS accumulation in CD4⁺ T cells, suppressed Th17-related responses, and enhanced Treg-associated immunoregulation. AS2863619 produced effects comparable to YCS, whereas Peptide P60 weakened Foxp3-associated immunoregulation; combined YCS treatment partially attenuated Peptide P60-induced changes. Conclusion: YGJ attenuated DED-related inflammatory injury in vivo and modulated lacrimal gland epithelial cell–CD4⁺ T-cell inflammatory interactions in vitro . These findings were accompanied by reduced lacrimal gland STAT3 phosphorylation in vivo and lower ROS accumulation in CD4⁺ T cells in vitro , together with Foxp3-associated improvement of the Th17/Treg balance; however, the causal relationship between the STAT3 and ROS findings was not established.

26 August 2026 in Cells
Verified
Journal Article
Open access
PDF file
YZYuan Zhong
Yuan Zhong
JPJun Peng*
Jun Peng*
QPQinghua Peng
Qinghua Peng
Dry eye disease (DED) exposes the ocular surface to persistent hyperosmolar, oxidative, metabolic, and inflammatory stress that may increase susceptibility to ferroptosis. Whether autophagy promotes or limits ferroptotic injury in DED remains unresolved. This review critically evaluates evidence from corneal and conjunctival epithelia, lacrimal glands, and meibomian glands, using non-ocular models only to interpret mechanisms not yet resolved in ocular tissues. We propose a threshold-balance framework in which autophagy has context-dependent effects. Ferritinophagy, lipophagy, and impaired autophagic flux can expand the labile iron pool, mobilize peroxidizable lipids, and promote lipid peroxidation. Conversely, intact autophagic–lysosomal flux and mitophagy can remove damaged cargo, limit mitochondrial oxidative stress, and preserve membrane antioxidant defenses. The balance between these processes may determine whether stressed ocular-surface cells adapt or progress toward ferroptotic injury, with consequences for epithelial barrier integrity, tear-film homeostasis, glandular secretion, and inflammation. Studies combining autophagy-related pathway perturbation with ferroptosis-related outcomes are concentrated in ocular-surface epithelial models, whereas this relationship has been less directly examined in lacrimal and meibomian tissues. Establishing causality will require flux-aware measurements, targeted pathway perturbation, tissue-resolved models, and functional validation in human samples. Such studies should clarify when and where autophagy–ferroptosis crosstalk is therapeutically actionable in DED.

31 August 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
XLXi Long
Xi Long
XPXin Peng
Xin Peng
GLGuicheng Liu
Guicheng Liu
PJPengfei Jiang
Pengfei Jiang
PLPei Liu
Pei Liu
QPQinghua Peng
Qinghua Peng
Background: Dry eye disease (DED) and anxiety are prevalent disorders that often coexist, yet the molecular mechanisms underlying their comorbidity remain inadequately understood. This study sought to elucidate the convergent genes, pathways, and immune signatures that link DED and anxiety by employing integrated bioinformatics and experimental validation approaches. Methods: Datasets (GSE44101, GSE98793) were retrieved from the GEO database. Weighted gene co-expression network analysis (WGCNA), differential expression analysis, and LASSO regression were utilized to identify candidate genes associated with comorbidity. Subsequently, functional enrichment analysis, protein–protein interaction network analysis, immune infiltration deconvolution, and single-cell RNA sequencing were conducted. A comorbid DED-anxiety mouse model was developed using a combination of desiccating stress, 0.2% benzalkonium chloride, and chronic unpredictable mild stress. The expression of hub genes was validated through reverse transcription quantitative polymerase chain reaction(RT-qPCR) and Western blotting. Results: Researchers identified 128 candidate genes enriched in pathways like circadian rhythm. Four key genes ( BTBD1 , BANK1 , UBA3 , NEDD1 ) were highlighted for their expression in corneal epithelium cells. Immune analysis linked these genes to plasma cells and B cell subsets. In a mouse model, symptoms of dry eye, anxiety, inflammation, and neurotransmitter imbalance were observed, with the hub genes upregulated. RT-qPCR and Western blot analyses confirmed significant upregulation of BTBD1 , BANK1 , UBA3 , and NEDD1 in corneal tissues, while in the lacrimal gland and hippocampus, BANK1 was elevated but BTBD1 , UBA3 , and NEDD1 were downregulated, indicating tissue-specific regulatory patterns. Conclusion: The study suggests BTBD1 , BANK1 , UBA3 , and NEDD1 are linked to immune-inflammatory features in DED-anxiety comorbidity, with distinct tissue-specific expression profiles observed across the cornea, lacrimal gland, and hippocampus, offering a basis for future research into shared pathways.

8 October 2026 in Cells
Verified
Journal Article
Open access
PDF file
YZYuan Zhong
Yuan Zhong
LLLiu Xiyuan Liu
Liu Xiyuan Liu
QPQinghua Peng
Qinghua Peng
JPJun Peng*
Jun Peng*
Reduced tear output can arise from altered neural regulation, impaired epithelial secretion, or loss of secretory tissue, with different implications for recovery. This focused narrative review integrates physiological, single-cell, spatial, organoid, and mechanistic studies identified through a structured PubMed search and targeted reference checking. We examine how remodeling of the lacrimal secretory niche affects acinar secretory competence, the capacity of viable acinar cells to convert stimulation into coordinated fluid, electrolyte, and protein secretion. Omics studies identify disease-associated expression patterns and candidate interactions, while selected perturbation studies link neural, inflammatory, and metabolic mechanisms to secretory dysfunction. We use residual functional reserve as a working concept for secretion that surviving tissue and its supporting niche can recruit through stimulation or relief of suppression. Potentially reversible functional suppression, persistent niche dysfunction, and structural failure describe overlapping constraints on secretion, not validated disease stages. These descriptions are distinct from the cellular, glandular, and lacrimal functional-unit levels at which outcomes are measured. The framework organizes questions about mechanism and recovery but does not establish a clinical treatment algorithm. Progress requires functional testing of candidate mechanisms and assessment of recovery at the level relevant to each claim.